These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2825668)

  • 1. w-oxidation products of leukotriene E4 in bile and urine of the monkey.
    Ball HA; Keppler D
    Biochem Biophys Res Commun; 1987 Oct; 148(2):664-70. PubMed ID: 2825668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and analysis of cysteinyl leukotrienes in the monkey.
    Denzlinger C; Guhlmann A; Scheuber PH; Wilker D; Hammer DK; Keppler D
    J Biol Chem; 1986 Nov; 261(33):15601-6. PubMed ID: 3023324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M; Müller J; Leier I; Jedlitschky G; Ball HA; Moore KP; Taylor GW; Williams R; Keppler D
    Eur J Biochem; 1990 Nov; 194(1):309-15. PubMed ID: 2174780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of peptide leukotrienes in the anesthetized rat.
    Foster A; Fitzsimmons B; Rokach J; Letts LG
    Biochim Biophys Acta; 1987 Oct; 921(3):486-93. PubMed ID: 2822131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halothane metabolism. Impairment of hepatic omega-oxidation of leukotrienes in vivo and in vitro.
    Huwyler J; Jedlitschky G; Keppler D; Gut J
    Eur J Biochem; 1992 Jun; 206(3):869-79. PubMed ID: 1318837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo formation of beta-oxidized metabolites of leukotriene E4 in the rat.
    Perrin P; Zirrolli J; Stene DO; Lellouche JP; Beaucourt JP; Murphy RC
    Prostaglandins; 1989 Jan; 37(1):53-60. PubMed ID: 2541469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and excretion of exogenous [3H]-LTC4 in primates.
    Tagari P; Foster A; Delorme D; Girard Y; Rokach J
    Prostaglandins; 1989 Jun; 37(6):629-40. PubMed ID: 2549573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo formation of omega-oxidized metabolites of leukotriene C4 in the rat.
    Orning L; Keppler A; Midtvedt T; Hammarström S
    Prostaglandins; 1988 Apr; 35(4):493-501. PubMed ID: 3247468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia and CCl4-induced liver injury, but not acidosis, impair metabolism of cysteinyl leukotrienes in perfused rat liver.
    Wettstein M; Gerok W; Häussinger D
    Hepatology; 1990 May; 11(5):866-73. PubMed ID: 2161395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotriene C4 metabolism by hepatoma cells and liver.
    Keppler D; Huber M; Weckbecker G; Hagmann W; Denzlinger C; Guhlmann A
    Adv Enzyme Regul; 1987; 26():211-24. PubMed ID: 2890280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omega-oxidation of cysteine-containing leukotrienes by rat-liver microsomes. Isolation and characterization of omega-hydroxy and omega-carboxy metabolites of leukotriene E4 and N-acetylleukotriene E4.
    Orning L
    Eur J Biochem; 1987 Dec; 170(1-2):77-85. PubMed ID: 2826163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukotriene C4 disposition and metabolism in the anesthetized and endotoxemic dog.
    Pfeifer CA; Bottoms GD; Johnson MA; Fessler J
    Circ Shock; 1991 Feb; 33(2):68-83. PubMed ID: 1675594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary defect of hepatobiliary cysteinyl leukotriene elimination in mutant rats with defective hepatic anion excretion.
    Huber M; Guhlmann A; Jansen PL; Keppler D
    Hepatology; 1987; 7(2):224-8. PubMed ID: 3030916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of hepatobiliary and renal elimination of cysteinyl leukotrienes by positron emission tomography.
    Guhlmann A; Krauss K; Oberdorfer F; Siegel T; Scheuber PH; Müller J; Csuk-Glänzer B; Ziegler S; Ostertag H; Keppler D
    Hepatology; 1995 Jun; 21(6):1568-75. PubMed ID: 7768501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the leukotriene receptor antagonists FPL 55712, LY 163443, and MK-571 on the elimination of cysteinyl leukotrienes in the rat.
    Denzlinger C; Grimberg M; Kapp A; Haberl C; Wilmanns W
    Br J Pharmacol; 1991 Apr; 102(4):865-70. PubMed ID: 1855116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of leukotrienes B4 and C4 in the isolated perfused rat lung.
    Harper TW; Westcott JY; Voelkel N; Murphy RC
    J Biol Chem; 1984 Dec; 259(23):14437-40. PubMed ID: 6094557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterohepatic circulation of N-acetyl-leukotriene E4.
    Guhlmann A; Hagmann W; Keppler D
    Prostaglandins; 1987 Jul; 34(1):63-70. PubMed ID: 3685398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the serine-borate complex on the relative ability of leukotriene C4, D4 and E4 to inhibit lung and brain [3H] leukotriene D4 and [3H] leukotriene C4 binding: demonstration of the agonists' potency order for leukotriene D4 and leukotriene C4 receptors.
    Cheng JB; Townley RG
    Biochem Biophys Res Commun; 1984 Mar; 119(2):612-7. PubMed ID: 6324769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of leukotriene E4 in isolated rat hepatocytes. Identification of beta-oxidation products of sulfidopeptide leukotrienes.
    Stene DO; Murphy RC
    J Biol Chem; 1988 Feb; 263(6):2773-8. PubMed ID: 2830262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary and urinary excretion of peptide leukotrienes in the domestic pig.
    Ezra D; Foster A; Cirino M; Rokach J; Letts LG
    Prostaglandins; 1987 May; 33(5):717-25. PubMed ID: 3588975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.